Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer

NCT06513455 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Irinotecan liposome（40mg/m2）
DRUG: Nab-paclitaxel
DRUG: Gemcitabine
DRUG: Irinotecan Liposome（60mg/m2）

Sponsor

Harbin Medical University